Chiron Shareholders Approve Novartis Acquisition
20 4월 2006 - 1:11AM
Business Wire
Chiron Corporation (NASDAQ:CHIR) today announced that Chiron
shareholders have approved the amended merger agreement under which
Novartis AG (NYSE:NVS) will acquire all Chiron shares it doesn't
already own for $48.00 per share in cash. At a special meeting of
Chiron shareholders held today, the merger was approved with more
than 85 percent of Chiron's total outstanding shares cast in favor
of the merger. As all necessary regulatory approvals were
previously received, Chiron expects the merger to close on
Thursday, April 20, 2006, at 12:01 a.m. PDT. About Chiron Chiron
delivers innovative and valuable products to protect human health
by advancing pioneering science across the landscape of
biotechnology. The company works to deliver on the limitless
promise of science and make a positive difference in people's
lives. For more information about Chiron, please visit
www.chiron.com.
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024